Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
save search
Progressive Care, Inc. Announces Reverse Stock Split and Will Trade Under Temporary Symbol RXMDD
Published: 2022-12-30 (Crawled : 15:00) - globenewswire.com
RXMD | $1.85 174.55% 4.9K
|
Retail Trade
|
| O: 916.95%
H: 2230.0%
C: 2066.67%
PARTY CITY SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Party City To Contact Him Directly To Discuss Their Options
Published: 2023-09-27 (Crawled : 22:00) - prnewswire.com
PRTYQ | $0.004 200.0% 28K
|
n/a
|
| O: -86.96%
H: 1566.67%
C: 833.33%
city
Week in Review: August 11, 2023
Published: 2023-08-14 (Crawled : 15:20) - myfw.com
FRCB | $0.04 18.59% 96K
|
n/a
|
| O: -87.1%
H: 712.5%
C: 700.0%
week
MicroCloud Hologram Planned to Join the Communications Industry Association
Published: 2024-02-07 (Crawled : 11:00) - prnewswire.com
HOLO | $2.9 29.46% 22.76% 37M
|
|
| O: 149.01%
H: 395.74%
C: 378.72%
association communications
Dais Shares Summary of Its Progress in 2022 With a Glimpse Into 2023
Published: 2023-01-17 (Crawled : 18:00) - globenewswire.com
DLYT | $0.0073 -17.6% 56K
|
|
| O: -79.0%
H: 366.67%
C: 366.67%
Tempest Adopts Limited Duration Stockholder Rights Plan
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
TPST | $3.18 -2.75% -2.83% 320K
|
Manufacturing
|
| O: 787.87%
H: 358.69%
C: 358.69%
Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC Study
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
TPST | $3.18 -2.75% -2.83% 320K
|
Manufacturing
|
| O: 787.87%
H: 358.69%
C: 358.69%
tpst-1120 arm study
Tempest to Report New and Updated Data from Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
Published: 2023-10-10 (Crawled : 20:00) - globenewswire.com
TPST | $3.18 -2.75% -2.83% 320K
|
Manufacturing
|
| O: 787.87%
H: 358.69%
C: 358.69%
tpst-1120 report global study
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
Published: 2023-12-19 (Crawled : 21:00) - biospace.com/
CMXC | $0.048 -63.33% 1.5K
|
Manufacturing
|
| O: 0.0%
H: 415.38%
C: 330.77%
ceo cell
Trevena Announces Approval of OLINVYK in China
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
TRVN | $0.3653 -9.13% -10.05% 1.2M
|
Health Technology
|
| O: 23.32%
H: 322.19%
C: 300.31%
approval olinvyk china
Avera Health and Theralink® Technologies Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care
Published: 2022-03-28 (Crawled : 17:00) - biospace.com/
THER | $0.001 62.5% 1.9M
|
n/a
|
| O: -80.0%
H: 400.0%
C: 300.0%
theralink health care collaboration cancer
Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
Published: 2024-04-01 (Crawled : 16:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: -75.0%
H: 1900.0%
C: 300.0%
Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes
Published: 2024-04-08 (Crawled : 12:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: -90.0%
H: 300.0%
C: 300.0%
offering
Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment
Published: 2022-12-09 (Crawled : 14:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: 185.44%
H: 288.03%
C: 288.03%
arx788 treatment breast positive cancer her2- her2 metastatic breast cancer
Rocky Mountain High Brands, Inc. Recaps Company’s OTC Quarterly Filings For 2023
Published: 2024-02-28 (Crawled : 14:00) - globenewswire.com
RMHB | $0.01 36.36% 450K
|
|
| O: -66.67%
H: 275.0%
C: 275.0%
Clubhouse Media Group, Inc. Closes Promo Deal With Rob Gronkowski, Four-Time Super Bowl Champion
Published: 2022-06-22 (Crawled : 13:00) - prnewswire.com
CMGR | $0.0003 -50.0% 14M
|
Health Care and Social Assistan...
|
| O: 12.0%
H: 671.43%
C: 246.43%
media deal
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Published: 2023-11-29 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 -2.66% 63K
|
Health Technology
|
| O: 171.75%
H: 308.97%
C: 243.67%
fda device treatment clearance therapeutics
SolarWindow Appoints New Directors and Auditor to Korean Subsidiary
Published: 2023-05-23 (Crawled : 15:00) - globenewswire.com
WNDW | $0.33 61.29% 8K
|
Manufacturing
|
| O: -79.17%
H: 240.0%
C: 240.0%
Mitesco Provides Shareholder Update
Published: 2024-02-15 (Crawled : 14:00) - globenewswire.com
MITI | News | $0.26 -9.99% 380
|
Manufacturing
|
| O: -69.23%
H: 524.5%
C: 225.0%
update
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
CADL | $5.49 0.92% 0.91% 740K
|
|
| O: 26.87%
H: 276.85%
C: 215.27%
can-2409 positive cancer pancreatic trial therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.